Laura K. Reed, MD(@LKReedMD) 's Twitter Profileg
Laura K. Reed, MD

@LKReedMD

MD❇️VA❇️TX 🧠PGY-6 Neurosurgery Resident at Baylor Scott & White in Temple, TX @bswhtemple_nsgy // 2025 CV Fellow // @NeurosurgeryCNS #SoMe //UMD //VCU MCV

ID:207680955

calendar_today25-10-2010 20:42:08

1,0K Tweets

1,0K Followers

850 Following

Neurosurgery(@neurosurgery) 's Twitter Profile Photo

February 2024 Journal Club Podcast: Global Outcomes for Microsurgical Clipping of Unruptured Intracranial Aneurysms: A Benchmark Analysis of 2245 Cases.

Listen now -> bit.ly/3SGJKV6

February 2024 Journal Club Podcast: Global Outcomes for Microsurgical Clipping of Unruptured Intracranial Aneurysms: A Benchmark Analysis of 2245 Cases. Listen now -> bit.ly/3SGJKV6
account_circle
Neurosurgery Publications(@NeurosurgeryCNS) 's Twitter Profile Photo

Time-Dosed Stereotactic Radiosurgery for the Treatment of Cerebral Arteriovenous Malformations: An Early Institution Experience and Case Series bit.ly/4bd8cpD by Sethi et al bit.ly/4bd8cpD CU School of Medicine Justin R. Mascitelli, MD, FAANS Ali M Alawieh Laura K. Reed, MD

#NEUPrac Time-Dosed Stereotactic Radiosurgery for the Treatment of Cerebral Arteriovenous Malformations: An Early Institution Experience and Case Series bit.ly/4bd8cpD by Sethi et al bit.ly/4bd8cpD @CUMedicalSchool @jmascite @AliAlawiehmdphd @LKReedMD
account_circle
Laura K. Reed, MD(@LKReedMD) 's Twitter Profile Photo

So proud of our team and our history! Our article was published just in time for the annual . It’s an honor to be part of the BSW Neurosurgery family.
cureus.com/articles/20841…

account_circle
JNIS(@JNIS_BMJ) 's Twitter Profile Photo

Just in: PEDVU(R) study results: Pipeline Vantage Embolization Device (PEDV) shows >90% occlusion rates in unruptured cohort at short/medium-term follow-up. Superior efficacy and similar safety in unruptured cases. bit.ly/3GNhKtc Thomas C Booth Biomedical Engineering & Imaging Sciences

Just in: PEDVU(R) study results: Pipeline Vantage Embolization Device (PEDV) shows >90% occlusion rates in unruptured cohort at short/medium-term follow-up. Superior efficacy and similar safety in unruptured cases. bit.ly/3GNhKtc @ThomasCBooth @KingsImaging #aneurysm
account_circle